Dr Eisenberg earned a BS in biology, a BA in psychology, and an MS in molecular biology from the State University of New York at Albany. She earned a PhD in molecular biology from the University of Kentucky. Her experience includes work with the National Institute of Environmental Health Sciences. Dr Eisenberg has been a member of the FBI’s Technical Working Group on DNA Analysis Methods and she was an appointed member of the National DNA Advisory Board during its lifespan. She has been recognized and honored for her contributions to the advancement of forensic DNA testing.
She currently holds certification in Molecular Genetics and Molecular Oncology and previously in Forensic DNA Testing and Paternity testing from the New York State Department of Health. Dr Eisenberg has been involved with the development and validation of hundreds of clinical assays used for patient care during her 25 plus year tenure at Labcorp and its predecessor company Roche Biomedical Laboratories and is currently Labcorp's Diagnostics Chief Scientific Officer and a Sr. Vice President.
Dr Eisenberg oversees Research and Development, Science and Technology for the company which includes test development, optimization and automation as well as Licensing and Business Development. She assists in the review of new tests, technologies and platforms and works with partners to transform their IP into viable diagnostic assays.
- Labcorp's perspective: Responding to SARS-CoV-2 and the next pandemic
- JAK2 exons 12, 13, 14 and 15 mutation analysis
- Microsatellite instability testing on solid tumors
- Characterization of more than 10,000 Zika virus test results in the US